Evidence map›Paper›PMID 34033529›Full record

ArticleAmerican journal of respiratory and critical care medicine2021

Importance of Lung Epithelial Injury in COVID-19-associated Acute Respiratory Distress Syndrome: Value of Plasma Soluble Receptor for Advanced Glycation End-Products.

Natacha Kapandji, Elise Yvin, Magali Devriese, Constance de Margerie-Mellon, Giulia Moratelli, Virginie Lemiale, Matthieu Jabaudon, Elie Azoulay, Jean-Michel Constantin, Guillaume Dumas

Open access · hybridAbstract readComparative StudyLetter
In one paragraph

Article in American journal of respiratory and critical care medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 25 citations in OpenAlex.

  1. Review
  2. Observational
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Article
  13. SARS-CoV-2 Infection and Lung Regeneration.Clinical microbiology reviews · 2022
    Review
  14. Article
  15. Article
  16. Review
  17. Predicting the Disease Severity of Virus Infection.Advances in experimental medicine and biology · 2022
    Article
  18. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Natacha KapandjiHôpital Saint-Louis Paris, France.
Elise YvinHôpital Saint-Louis Paris, France.
Magali DevrieseHôpital Saint-Louis Paris, France.
Constance de Margerie-MellonHôpital Saint-Louis Paris, France.
Giulia MoratelliHôpital Saint-Louis Paris, France.
Virginie LemialeHôpital Saint-Louis Paris, France.
Matthieu JabaudonCHU ClermontFerrand and Université Clermont Auvergne ClermontFerrand, France.ORCID 0000-0002-8121-1680
Elie AzoulayHôpital Saint-Louis Paris, France.
Jean-Michel ConstantinSorbonne University and PitiéSalpêtrière Hospital Paris, France.
Guillaume DumasHôpital Saint-Louis Paris, France.
Université Paris Cité · FRAssistance Publique – Hôpitaux de Paris · FRHôpital Saint-Louis · FRSorbonne Université · FRUniversité Clermont Auvergne · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Acute Lung InjuryAgedBiomarkersCOVID-19Epithelial CellsFemaleFranceGlycation End Products, AdvancedHumansMaleMiddle AgedReceptor for Advanced Glycation End ProductsRespiratory Distress SyndromeSARS-CoV-2BiomarkersGlycation End Products, AdvancedReceptor for Advanced Glycation End Products

Identifiers

PMID34033529
PMCPMC8513587
OpenAlexW3163999468

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.